Dorsey & Whitney Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

Dorsey & Whitney Trust’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373K	Sell	694 -51	-7%	-$26.1K	0.02%	515
2026 Q1	$390K	Sell	745 -7	-0.9%	-$3.34K	0.02%	493
2025 Q4	$438K	Hold	752	–	–	0.02%	458
2025 Q3	$345K	Hold	752	–	–	0.02%	506
2025 Q2	$228K	Sell	752 -39	-5%	-$11.6K	0.01%	607
2025 Q1	$262K	Sell	791 -43	-5%	-$14.1K	0.02%	554
2024 Q4	$257K	Buy	+834	New	+$235K	0.01%	571
2024 Q3	–	Sell	-934	Closed	-$262K	–	680
2024 Q2	$262K	Buy	+934	New	+$222K	0.02%	519

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dorsey & Whitney Trust's MDGL Position: Q2 2026 in Review

Dorsey & Whitney Trust reduced its Madrigal Pharmaceuticals (MDGL) stake by 6.8% in Q2 2026, selling an estimated $26.1K and leaving 694 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #515.

Dorsey & Whitney Trust first reported a position in MDGL in Q2 2024 and has held it in 8 quarters since. The position peaked at $438K in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Dorsey & Whitney Trust held 694 shares of Madrigal Pharmaceuticals worth $373K as of Q2 2026.
Dorsey & Whitney Trust sold 51 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $26.1K.
Madrigal Pharmaceuticals made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #515 holding.
Dorsey & Whitney Trust first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Dorsey & Whitney Trust's Madrigal Pharmaceuticals position peaked at $438K in Q4 2025.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.